Michael Hutchinson

31.9k total citations · 5 hit papers
295 papers, 21.8k citations indexed

About

Michael Hutchinson is a scholar working on Neurology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Michael Hutchinson has authored 295 papers receiving a total of 21.8k indexed citations (citations by other indexed papers that have themselves been cited), including 123 papers in Neurology, 115 papers in Pathology and Forensic Medicine and 58 papers in Cellular and Molecular Neuroscience. Recurrent topics in Michael Hutchinson's work include Multiple Sclerosis Research Studies (103 papers), Neurological disorders and treatments (67 papers) and Botulinum Toxin and Related Neurological Disorders (55 papers). Michael Hutchinson is often cited by papers focused on Multiple Sclerosis Research Studies (103 papers), Neurological disorders and treatments (67 papers) and Botulinum Toxin and Related Neurological Disorders (55 papers). Michael Hutchinson collaborates with scholars based in Ireland, United States and United Kingdom. Michael Hutchinson's co-authors include Eva Havrdová, Fred Lublin, Chris H. Polman, Paul O’Connor, Ludwig Kappos, Alan J. Thompson, Massimo Filippi, Xavier Montalbán, Stephen C. Reingold and M. Clanet and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Michael Hutchinson

286 papers receiving 21.2k citations

Hit Papers

Diagnostic criteria for m... 1998 2026 2007 2016 2011 2006 1998 2012 2008 2.5k 5.0k 7.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
    2011 7.6k citations Stephen C. Reingold, Massimo Filippi et al. profile →
  2. A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
    2006 2.4k citations Eva Havrdová, Michael Hutchinson et al. profile →
  3. Rate of Pregnancy-Related Relapse in Multiple Sclerosis
    1998 1.1k citations Michael Hutchinson et al. profile →
  4. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis
    2012 1.0k citations Robert J. Fox, J. Theodore Phillips et al. profile →
  5. Differential diagnosis of suspected multiple sclerosis: a consensus approach
    2008 440 citations DH Miller, Massimo Filippi et al. Multiple Sclerosis Journal profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Hutchinson Ireland 54 13.9k 6.6k 3.6k 3.6k 3.4k 295 21.8k
Per Soelberg Sørensen Denmark 73 13.2k 1.0× 5.7k 0.9× 3.8k 1.1× 3.4k 0.9× 3.6k 1.1× 447 21.8k
Richard A. Rudick United States 71 16.0k 1.2× 5.5k 0.8× 3.4k 0.9× 4.1k 1.1× 2.9k 0.9× 214 21.7k
Jeffrey A. Cohen United States 69 13.2k 1.0× 5.6k 0.9× 3.1k 0.9× 3.2k 0.9× 2.6k 0.8× 314 22.7k
Gavin Giovannoni United Kingdom 79 14.1k 1.0× 7.2k 1.1× 4.4k 1.2× 3.2k 0.9× 4.2k 1.3× 678 26.2k
Stephen C. Reingold United States 33 21.4k 1.5× 7.3k 1.1× 3.2k 0.9× 5.7k 1.6× 3.4k 1.0× 56 26.0k
Emmanuelle Waubant United States 57 15.3k 1.1× 6.1k 0.9× 2.9k 0.8× 3.6k 1.0× 4.1k 1.2× 228 21.0k
Paul O’Connor Canada 52 19.7k 1.4× 6.9k 1.0× 5.1k 1.4× 4.8k 1.3× 4.3k 1.3× 152 25.1k
Bianca Weinstock‐Guttman United States 75 15.3k 1.1× 5.7k 0.9× 2.4k 0.7× 3.5k 1.0× 1.9k 0.6× 518 20.5k
Jerry S. Wolinsky United States 58 23.4k 1.7× 8.6k 1.3× 4.0k 1.1× 6.5k 1.8× 3.9k 1.2× 243 28.5k
Tanuja Chitnis United States 64 11.2k 0.8× 5.7k 0.9× 2.3k 0.6× 2.9k 0.8× 3.8k 1.1× 365 17.6k

Countries citing papers authored by Michael Hutchinson

Since Specialization
Citations

This map shows the geographic impact of Michael Hutchinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Hutchinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Hutchinson more than expected).

Fields of papers citing papers by Michael Hutchinson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Hutchinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Hutchinson. The network helps show where Michael Hutchinson may publish in the future.

Co-authorship network of co-authors of Michael Hutchinson

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Hutchinson. A scholar is included among the top collaborators of Michael Hutchinson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Hutchinson. Michael Hutchinson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bar‐Or, Amit, Ralf Gold, Robert J. Fox, et al.. (2015). Five-Year Follow-up of Delayed-Release Dimethyl Fumarate in RRMS: Integrated Clinical Efficacy Data from the DEFINE, CONFIRM, and ENDORSE Studies (P7.234). Neurology. 84(14_supplement). 7 indexed citations
3.
Tolley, Keith, Michael Hutchinson, Andrew R. Pachner, et al.. (2014). Systematic Literature Review and Network Meta-Analysis of Pegylated Interferon Beta-1a and Disease Modifying Therapies for Relapsing-Remitting Multiple Sclerosis (P7.234). Neurology. 82(10_supplement). 1 indexed citations
4.
5.
6.
Hutchinson, Michael, J. Theodore Phillips, D. H. Miller, et al.. (2013). Efficacy and Safety of BG-12 (Dimethyl Fumarate) in Relapsing-Remitting Multiple Sclerosis in the Phase 3 CONFIRM Study. UCL Discovery (University College London). 1 indexed citations
7.
Miller, D. H., et al.. (2012). Effect of BG-12 on magnetic resonance imaging activity in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study. UCL Discovery (University College London). 3 indexed citations
8.
Havrdová, Eva, D. H. Miller, J. Theodore Phillips, et al.. (2012). Clinical and neuroimaging outcomes with BG-12 treatment in CONFIRM (comparator and an oral fumarate in relapsing-remitting multiple sclerosis), a multicenter, randomized, placebo-controlled, phase-3 study. UCL Discovery (University College London). 2 indexed citations
9.
Hutchinson, Michael, D. H. Miller, J. Theodore Phillips, et al.. (2012). Effect of BG-12 in subgroups of patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis) study. UCL Discovery (University College London). 2 indexed citations
10.
Miller, D. H., J. Theodore Phillips, Michael Hutchinson, et al.. (2012). Effects of BG-12 on magnetic resonance imaging outcomes in CONFIRM (Comparator and an Oral Fumarate in Relapsing-Remitting Multiple Sclerosis), a randomized, placebo-controlled, phase 3 study. UCL Discovery (University College London). 3 indexed citations
11.
Hutchinson, Michael. (2010). Natalizumab Therapy of Multiple Sclerosis. Journal of Interferon & Cytokine Research. 30(10). 787–789. 4 indexed citations
12.
Walsh, Richard A., Robert Whelan, Séan O’Riordan, et al.. (2009). Striatal morphology correlates with sensory abnormalities in unaffected relatives of cervical dystonia patients. Journal of Neurology. 256(8). 1307–1313. 19 indexed citations
13.
Miller, DH, Massimo Filippi, JA Cohen, et al.. (2008). Differential diagnosis of suspected multiple sclerosis: a consensus approach. Multiple Sclerosis Journal. 14(9). 1157–1174. 440 indexed citations breakdown →
14.
Hanein, Sylvain, Elodie Martin, Amir Boukhris, et al.. (2008). Identification of the SPG15 Gene, Encoding Spastizin, as a Frequent Cause of Complicated Autosomal-Recessive Spastic Paraplegia, Including Kjellin Syndrome. The American Journal of Human Genetics. 82(4). 992–1002. 148 indexed citations
15.
Costelloe, Lisa, Killian O’Rourke, Hugh Kearney, et al.. (2007). The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical). Journal of Neurology Neurosurgery & Psychiatry. 78(8). 841–844. 110 indexed citations
16.
Hutchinson, Michael & Ulrich Raff. (2007). On false negatives in MRI studies of Parkinson disease. Movement Disorders. 22(10). 1521–1522. 3 indexed citations
17.
Crown, John, et al.. (2005). Fragile X-associated tremor/ataxia syndrome presenting in a woman after chemotherapy. Neurology. 65(2). 331–332. 36 indexed citations
18.
Schiffman, Mark, Rolando Herrero, Allan Hildesheim, et al.. (2001). HPV DNA Testing in Cervical Cancer Screening: Results from Women in a High‐Risk Province of Costa Rica. Journal of Lower Genital Tract Disease. 5(1). 56–57. 21 indexed citations
19.
Redmond, Janice, Alan J. Thompson, & Michael Hutchinson. (1983). Acute central cervical cord injury due to disco dancing.. BMJ. 286(6379). 1704.1–1704. 4 indexed citations
20.
Hutchinson, Michael & C. Young. (1962). Educating the intelligent. Penguin eBooks. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Per Soelberg Sørensen Breakdown of academic impact, for papers by Richard A. Rudick Breakdown of academic impact, for papers by Jeffrey A. Cohen Breakdown of academic impact, for papers by Gavin Giovannoni Breakdown of academic impact, for papers by Stephen C. Reingold Breakdown of academic impact, for papers by Emmanuelle Waubant Breakdown of academic impact, for papers by Paul O’Connor Breakdown of academic impact, for papers by Bianca Weinstock‐Guttman Breakdown of academic impact, for papers by Jerry S. Wolinsky Breakdown of academic impact, for papers by Tanuja Chitnis
Rankless by CCL
2026